Recombinant beta-serine-interferon in ha
β
John A. Glaspy; Steven G. Marcus; Jan Ambersley; David W. Golde
π
Article
π
1989
π
John Wiley and Sons
π
English
β 440 KB
π 1 views
Ten patients with hairy cell leukemia (HCL) requiring therapy were treated with recombinant beta-serineinterferon (rIFN-Bser) (90 X lo6 units [Ul subcutaneously three times a week). Eight patients were evaluable for response and nine for toxicity. Five patients (63%) showed normalization of peripher